Wedge Capital Management L L P Abb Vie Inc. Transaction History

Wedge Capital Management L L P

$5.71 Billion
Q3 2024

A detailed history of Wedge Capital Management L L P transactions in Abb Vie Inc. stock. As of the latest transaction made, Wedge Capital Management L L P holds 164,552 shares of ABBV stock, worth $28.3 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

164,552

Previous 212,439 22.54%

Holding current value

$28.3 Million

Previous $36.4 Million 10.82%

% of portfolio

0.57%

Previous 0.65%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$163.84 - $199.33 $7.85 Million - $9.55 Million	-47,887 Reduced 22.54%	164,552 $32.5 Million
Q2 2024 Jul 17, 2024	SELL	$154.79 - $180.76 $959,543 - $1.12 Million	-6,199 Reduced 2.84%	212,439 $36.4 Million
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $2.03 Million - $2.31 Million	12,673 Added 6.15%	218,638 $39.8 Million
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $1.12 Million - $1.26 Million	-8,155 Reduced 3.81%	205,965 $31.9 Million
Q3 2023 Oct 13, 2023	SELL	$133.59 - $154.65 $1.94 Million - $2.24 Million	-14,492 Reduced 6.34%	214,120 $31.9 Million
Q2 2023 Jul 17, 2023	SELL	$132.51 - $164.9 $1.28 Million - $1.59 Million	-9,655 Reduced 4.05%	228,612 $30.8 Million
Q1 2023 Apr 11, 2023	SELL	$144.61 - $166.54 $1.39 Million - $1.6 Million	-9,596 Reduced 3.87%	238,267 $38 Million
Q4 2022 Jan 17, 2023	SELL	$138.31 - $165.87 $1.13 Million - $1.36 Million	-8,172 Reduced 3.19%	247,863 $40.1 Million
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $1.15 Million - $1.31 Million	8,532 Added 3.45%	256,035 $34.4 Million
Q2 2022 Jul 11, 2022	BUY	$137.62 - $174.96 $3.17 Million - $4.03 Million	23,055 Added 10.27%	247,503 $37.9 Million
Q1 2022 Apr 12, 2022	SELL	$131.98 - $163.75 $7 Million - $8.68 Million	-53,026 Reduced 19.11%	224,448 $36.4 Million
Q4 2021 Jan 24, 2022	BUY	$107.43 - $135.93 $672,189 - $850,514	6,257 Added 2.31%	277,474 $37.6 Million
Q3 2021 Oct 14, 2021	SELL	$106.4 - $120.78 $1.38 Million - $1.56 Million	-12,955 Reduced 4.56%	271,217 $29.3 Million
Q2 2021 Jul 14, 2021	SELL	$105.21 - $117.21 $900,808 - $1 Million	-8,562 Reduced 2.92%	284,172 $32 Million
Q1 2021 Apr 12, 2021	BUY	$102.3 - $112.62 $29.9 Million - $33 Million	292,734 New	292,734 $31.7 Million
Q3 2020 Oct 08, 2020	SELL	$85.91 - $100.83 $339,774 - $398,782	-3,955 Closed	0 $0
Q2 2020 Jul 10, 2020	BUY	$73.37 - $98.18 $33,676 - $45,064	459 Added 13.13%	3,955 $388,000
Q1 2020 Apr 13, 2020	SELL	$64.5 - $97.79 $30.2 Million - $45.8 Million	-468,323 Reduced 99.26%	3,496 $266,000
Q4 2019 Jan 15, 2020	SELL	$72.13 - $90.25 $945,984 - $1.18 Million	-13,115 Reduced 2.7%	471,819 $41.8 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $2.98 Million - $3.58 Million	47,265 Added 10.8%	484,934 $36.7 Million
Q2 2019 Aug 01, 2019	BUY	$65.7 - $83.98 $28.8 Million - $36.8 Million	437,669 New	437,669 $31.8 Million
Q1 2019 May 02, 2019	SELL	$77.14 - $90.79 $178,424 - $209,997	-2,313 Closed	0 $0
Q4 2018 Jan 31, 2019	SELL	$77.85 - $96.01 $7,473 - $9,216	-96 Reduced 3.99%	2,313 $213,000
Q3 2018 Nov 01, 2018	BUY	$88.91 - $98.84 $14,759 - $16,407	166 Added 7.4%	2,409 $228,000
Q2 2018 Jul 31, 2018	BUY	$89.78 - $106.23 $201,376 - $238,273	2,243 New	2,243 $208,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

News

Stay updated on Wedge Capital Management L L P with notifications on news.

Account

Wedge Capital Management L L P Abb Vie Inc. Transaction History